At a glance: Treatment for PANS and PANDAS generally works toward three goals simultaneously: identifying and treating any active or recent infection, addressing the immune system dysfunction driving brain inflammation, and managing the neuropsychiatric symptoms the child is experiencing. The right combination and sequence of approaches depends on the individual child's presentation, episode history, and what a thorough evaluation finds.
What Does Treatment for PANS or PANDAS Actually Look Like? Treatment for PANS and PANDAS generally works toward three goals simultaneously: identifying and treating any active or recent infection, addressing the immune system dysfunction driving brain inflammation, and managing the neuropsychiatric symptoms the child is experiencing. The right combination and sequence of approaches depends on the individual child's presentation, episode history, and what a thorough evaluation finds — and for many families, the biomedical and natural support layer is where the most day-to-day management actually happens.
One of the most disorienting things about getting a PANS or PANDAS diagnosis — or even a strong clinical suspicion of one — is that treatment is not a single clear path. There is no one protocol that every provider follows in the same order for every child. That uncertainty is hard to sit with when your child is struggling in front of you and you need to know what to do next.
What is helpful is understanding the framework that experienced providers work within. Treatment for PANS and PANDAS addresses three distinct but interconnected problems at once: the infection or immune trigger, the immune response that trigger set off, and the neuropsychiatric symptoms that immune response is producing. Understanding what each of those layers involves — and how they relate to each other — gives you a framework for making sense of your medical team's recommendations, asking better questions, and tracking whether what is being tried is working.
The first question in any PANS or PANDAS evaluation is whether there is an active or recent infection that needs to be identified and treated. For PANDAS specifically, that means a thorough strep investigation — not just a rapid test, but an overnight culture, strep antibody titers, and consideration of strep in sites beyond the standard throat swab. For PANS more broadly, it means looking at the full range of potential triggers: Mycoplasma pneumoniae, Lyme disease, influenza, and other organisms that have been associated with PANS onset.
When a bacterial infection is identified, antibiotics are a standard part of the initial treatment approach. For strep-triggered PANDAS, this typically means a full course of an appropriate antibiotic — not the abbreviated courses sometimes used for routine strep throat. For Mycoplasma-triggered PANS, a different class of antibiotic is needed, since Mycoplasma does not respond to the same antibiotics that treat strep.
It is worth being clear about what antibiotics do and do not accomplish here. They treat an active infection. They do not directly address the immune response and neuroinflammation that the infection has already set in motion. In children with milder presentations or a first episode, treating the infection may be sufficient for the immune response to settle on its own over time. In children with more severe or persistent presentations, additional treatment targeting the immune response is typically part of the picture.
This is the layer that distinguishes PANS and PANDAS treatment from standard infection management — and the one that is most variable across providers and most dependent on the individual child's clinical picture.
The immune response driving PANS and PANDAS symptoms is not resolved simply by clearing the infection that triggered it. In many children, the immune system continues producing the antibodies and inflammatory signals that are causing neurological symptoms long after the original infection is gone. Addressing that ongoing immune process is the second treatment goal.
💡 Think of it this way: Someone sets off a fire alarm in a building. Even after the small fire is put out, the alarm keeps ringing. The first step is putting out the fire — that is treating the infection. But if the alarm keeps ringing after the fire is out, you need to address the alarm system itself. That is what immune-directed treatment is doing — resetting an alarm system that has not turned off on its own.
Anti-inflammatory approaches are often part of this layer. Non-steroidal anti-inflammatory medications are sometimes used in the short term to help reduce inflammation and may provide some symptom relief. Short courses of corticosteroids are used by some providers in specific clinical situations, though this is an area where provider practice varies and the evidence base is still developing.
For children who do not respond adequately to initial treatment, or who present with moderate to severe symptoms from the start, more intensive immune-directed therapies — IVIG and plasmapheresis — are sometimes discussed. However, it is important for families to understand that in practice, these interventions are prescribed far less often than the literature might suggest. IVIG in particular faces significant real-world barriers: it is a blood-based product with real risks, insurance coverage is difficult to obtain and frequently denied, and many experienced providers exhaust a great deal of other options before arriving there. Plasmapheresis is even less commonly used and is reserved for the most severe, treatment-resistant cases at specialized centers. These articles in this series cover both in more detail, but families should not assume that IVIG or plasmapheresis represents the expected next step when initial treatment is insufficient. For most children, it does not.
This layer is one that experienced integrative providers find essential — and one that is frequently absent from purely conventional treatment discussions. For many families navigating PANS and PANDAS, biomedical and natural immune support is not a supplement to treatment. It is where the majority of ongoing management actually happens.
The reasoning is grounded in biology. PANS and PANDAS are fundamentally driven by immune dysregulation and neuroinflammation. Approaches that support the immune system, calm inflammatory pathways, and restore biological balance address those underlying processes in a way that complements — and sometimes reduces the need for — more aggressive conventional interventions.
Herbal and botanical antimicrobials are used by some integrative providers as primary or adjunctive treatment for the infectious component, particularly in children with milder presentations or in families who are navigating antibiotic sensitivity or gut concerns. Herbs with documented antimicrobial and immune-modulating properties — including Japanese knotweed, cat's claw, and others — are part of the integrative toolkit, used thoughtfully and with dosing guidance from an experienced provider.
Natural resolvins and anti-inflammatory support address the neuroinflammation layer through pathways that are distinct from pharmaceutical anti-inflammatories. Omega-3 fatty acids — particularly high-quality fish oil containing EPA and DHA — support the production of resolvins and protectins, which are the body's own inflammation-resolving molecules. These are not simply mild supportive measures. The biology of specialized pro-resolving mediators is an active area of research, and their role in calming neuroinflammation is clinically meaningful.
Immune-modulating supplements support the immune system's ability to regulate itself rather than amplify its misfiring. These include:
Glutathione and antioxidant support help address the oxidative stress burden that accompanies significant immune activation, supporting cellular recovery in the nervous system.
None of these are prescriptions for every child, and none should be started without provider guidance — particularly when a child is already on prescription medications. The appropriate combination, dosing, and sequencing depends on the individual child's biological picture. What matters is that these options exist, are used regularly by experienced integrative providers, and for many families represent the most accessible, sustainable, and well-tolerated aspect of their child's ongoing care.
The infection is being treated. The immune response is being addressed. But the child in front of you is still struggling with OCD, anxiety, rage, food refusal, and sleep disruption. That reality does not wait for the biological layers to fully resolve — it needs to be managed in parallel.
Cognitive Behavioral Therapy using Exposure and Response Prevention — CBT/ERP — is the most well-supported behavioral treatment for OCD and anxiety, and most providers experienced in PANS and PANDAS include it as an important part of comprehensive treatment. During an acute, severe episode when the brain is actively inflamed, a child may not have the neurological capacity to engage with intensive behavioral work. Experienced therapists who understand these conditions know how to adjust the intensity during acute phases and pursue it more fully as the episode settles.
In some cases, carefully managed psychiatric medications play a supporting role — particularly when anxiety or mood dysregulation is severe enough to interfere with functioning. Children with PANS and PANDAS are frequently reported to be more sensitive to psychiatric medications than other children, which is a critical consideration for any provider making those recommendations. Starting low and going slow is particularly important in this population.
The most important thing to understand about PANS and PANDAS treatment is that these layers are not sequential. You do not finish one before starting the next. They are pursued simultaneously, with each informing and supporting the others.
A child whose infection is being treated but whose immune response is not addressed will likely continue to struggle neuropsychiatrically. A child whose neuropsychiatric symptoms are being managed behaviorally but whose biological process is ongoing is working against a current that keeps pulling them back. The most effective treatment holds all the layers at once — addressing the biology and supporting the child's neurological and behavioral recovery in parallel.
This is also why treatment works best as a team effort. A provider who can manage the infectious and immune aspects, a therapist trained in CBT/ERP who understands PANS and PANDAS, and when relevant a provider who can guide the biomedical and natural support layer — ideally communicating with each other — is the structure that gives children the best foundation for recovery.
Treatment for PANS and PANDAS is rarely a straight line. Improvement often comes unevenly — some better days followed by harder ones, particularly around illnesses or periods of immune activation. This is not a sign that treatment is failing. It is a reflection of how these conditions work.
What experienced providers help families track is the overall trajectory over weeks and months, not daily fluctuation. A child who is having more good days than bad, whose acute episodes are less severe than earlier ones, whose recovery time after a flare is shortening — that child is improving, even on the hard days.
Small improvements — better sleep, fewer raging episodes, more food acceptance, less intense OCD rituals — are real progress. They are worth naming and tracking, because they are the foundation that more complete recovery is built on.
💬 If this framework is clicking for you and you're tired of piecing things together from random posts and forums, consider joining the Spectrum Care Hub Learning Community. You'll get full access to step-by-step biomedical coursework, printable tools, and new lessons added every month. Click here for details
How long does treatment for PANS or PANDAS typically take? There is no single timeline that applies to every child. Duration depends on how quickly the triggering infection was identified and treated, how severe the episode was, how many prior episodes have occurred, and how the individual child's immune system responds. Some children improve substantially within weeks of appropriate treatment. Others have a longer, more uneven course. Earlier identification and treatment is consistently associated with better outcomes — which is one of the strongest reasons timely diagnosis matters.
Should we pursue all these layers at once, or one at a time? Most experienced providers pursue them simultaneously rather than sequentially, because the neuropsychiatric symptoms do not wait for the biological layers to resolve. Practical sequencing — which specific interventions to start first and how to add others — is made based on the individual child's presentation. This is a conversation for a provider experienced in PANS and PANDAS rather than a fixed protocol.
What if my child's symptoms improve with antibiotics and then come back when the course ends? This is a pattern that experienced providers recognize and take seriously. It may suggest a longer course is warranted, that prophylactic antibiotics are worth discussing, that there is a reservoir of strep that has not been fully cleared, or that the immune response needs more direct treatment than antibiotics alone can provide. Bring this pattern specifically to your provider's attention — it is clinically informative.
How do we find a therapist who understands PANS and PANDAS and can deliver CBT/ERP appropriately? The International OCD Foundation at iocdf.org maintains a therapist directory that allows filtering by OCD specialty and CBT/ERP training. When contacting potential therapists, ask specifically whether they have experience with PANS and PANDAS and whether they know how to adjust CBT/ERP intensity during acute episodes.
My child's provider has only mentioned antibiotics. How do I ask about the biomedical and natural support layer? You can ask directly: "Are there supplements or natural anti-inflammatory approaches that would be appropriate to consider alongside the antibiotic treatment?" A provider familiar with integrative PANS and PANDAS care will be able to discuss options based on your child's specific picture. If your current provider is not familiar with this layer, finding one who practices integrative medicine alongside conventional PANS and PANDAS management is a reasonable step.
How do I know if IVIG is actually something my child needs? IVIG is considered for children who have not responded adequately to multiple other approaches and who have moderate to severe, persistent presentations. In practice it is rarely the next step after antibiotics — many other options are explored first. If a provider recommends it, it is appropriate to ask what other approaches have been considered, why IVIG is being recommended at this point, and what the realistic picture looks like for insurance coverage and the process involved.
💬 If this helped you see your child's behavior and biology in a new light, the next step is to keep building on that clarity. Our Spectrum Care Hub subscription gives you the complete course library, deeper dive modules, and ongoing support, so you don't have to navigate autism and PANS/PANDAS care alone. Click here for details
Last reviewed by Mary Margaret Burch, FNP-BC — March 2026 © 2026 Spectrum Care Hub LLC / SpectrumCareHub.com. This article is for educational purposes only. Nothing here constitutes medical advice or creates a provider-patient relationship. Always work with a qualified, licensed healthcare provider before making any medical decisions for your child.